Evogene LtdNASDAQ:EVGN
- LAST PRICE1.6150
- TODAY'S CHANGE (%)-0.0720 (-4.2679%)
- Bid / Lots1.5700/ 1
- Ask / Lots1.6600/ 2
- Open / Previous Close1.6800 / 1.6870
- Day Range
- 52 Week Range
- Volume20,616
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EVGN |
|---|---|---|
| 09:32 ET | 3030 | 1.68 |
| 09:33 ET | 2100 | 1.71 |
| 09:35 ET | 1000 | 1.6901 |
| 09:37 ET | 313 | 1.69 |
| 09:53 ET | 256 | 1.6683 |
| 10:04 ET | 4600 | 1.6815 |
| 10:13 ET | 5810 | 1.6601 |
| 10:42 ET | 120 | 1.66 |
| 10:45 ET | 600 | 1.62 |
| 10:51 ET | 100 | 1.6504 |
| 11:18 ET | 100 | 1.615 |
Nov 21, 2024
Evogene Reports Third Quarter 2024 Financial Results, from 7:30AM ET on Thursday Nov 21, 2024 by Dow Jones
7:30AM ET on Thursday Nov 21, 2024 by Dow JonesPress Release: Evogene Reports Third Quarter 2024 Financial Results, from 7:30AM ET on Thursday Nov 21, 2024 by Dow Jones
7:30AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 19, 2024
Nov 12, 2024
Lavie Bio Announces Commercial Expansion of Yalos(R) as Seed-Treatment for Soybean, Following Successful Field Trials, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 7, 2024
Evogene Schedules Third Quarter 2024 Financial Results Release, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Evogene Ltd | 8.5M | -0.4x | --- |
Stemtech Corp | 7.4M | -1.1x | --- |
Plus Therapeutics Inc | 7.4M | -0.5x | --- |
Kineta Inc | 3.7M | -0.2x | --- |
Redhill Biopharma Ltd | 10.2M | 0.0x | --- |
Petros Pharmaceuticals Inc | 2.7M | -0.1x | --- |
Company Information
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Contact Information
- Headquarters
- 13 Gad Feinstein Street, Park RehovotREHOVOT, Israel 7638517
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Sarit Firon
- President, Chief Executive Officer
- Ofer Haviv
- Chief Financial Officer
- Dorit Kreiner
- Chief Executive Officer of AgPlenus Limited
- Brian Ember
- Chief Executive Officer of Biomica Limited
- Elran Haber
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.5M |
|---|---|
Revenue (TTM) | $7.5M |
Shares Outstanding | 5.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.38 |
EPS | $-4.44 |
Book Value | $2.38 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -330.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
